SYM insider plans sale of 6,667 shares

SYM insider Maria G. Freve has filed a Form 144 notice to sell up to 6,667 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $399,956.88, on or after 01/26/2026 on NASDAQ.

Accepted by SEC EDGAR 01/26/2026 - 04:13 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

SYM insider Maria G. Freve has filed a Form 144 notice to sell up to 6,667 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $399,956.88, on or after 01/26/2026 on NASDAQ.

The 6,667 shares come from restricted stock that vested on 01/23/2026 under a registered plan, received from the issuer as compensation for services rendered. Over the past three months, Freve has already sold 1,666 shares for $96,838.20 and 662 shares for $46,929.30.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does SYM's latest Form 144 filing disclose?

The filing shows that Maria G. Freve intends to sell up to 6,667 shares of SYM common stock, with an aggregate market value of $399,956.88, under Rule 144.

How did Maria G. Freve acquire the SYM shares she plans to sell?

She acquired the 6,667 common shares on 01/23/2026 as restricted stock vesting under a registered plan from the issuer, as compensation for services rendered.

Through which broker and exchange will the SYM shares be sold?

The proposed sale is through Morgan Stanley Smith Barney LLC Executive Financial Services, with the stock listed for sale on the NASDAQ.

What recent SYM stock sales has Maria G. Freve already completed?

In the past three months, she sold 1,666 SYM common shares for $96,838.20 on 11/17/2025 and 662 shares for $46,929.30 on 10/28/2025.

How many SYM shares are outstanding according to the Form 144?

The notice lists 113,614,046 shares of SYM common stock outstanding at the time of the filing.

What representation does the seller make in the SYM Form 144?

By signing, the seller represents that they do not know any material adverse information about SYM's current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001807561
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Symbotic Inc.
SEC File Number	001-40175
Address of Issuer	200 Research Drive Wilmington MASSACHUSETTS 01887
Phone	978-284-2800
Name of Person for Whose Account the Securities are To Be Sold	MARIA G FREVE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6667	399956.88	113614046	01/26/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/23/2026	Restricted stock vesting under a registered plan	Issuer			6667	01/23/2026	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MARIA G FREVE 200 Research Drive Wilmington MA 01887	Common	11/17/2025	1666	96838.20
MARIA G FREVE 200 Research Drive Wilmington MA 01887	Common	10/28/2025	662	46929.30

144: Remarks and Signature

Remarks
Date of Notice	01/26/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Marie G Freve
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)